Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Control Subjects From the GSK HPV-023 Study

NCT01418937 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01418937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01418937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Control Subjects From the GSK HPV-023 Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
May 29, 2012
Completion date
January 9, 2015
Enrollment
164 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus